Low-density lipoprotein-cholesterol (LDL-C) and the average lipid-lowering potency (ALLP) in nurse-coordinated care (NCC) versus usual care patients at baseline and 6 and 12 months follow-up
| Baseline* | F6 | F12 | ||||||
| Parameter | NCC (n=365) | Usual care (n=367) | NCC (n=356) | Usual care (n=346) | p Value† | NCC (n=357) | Usual care (n=352) | p Value† |
| On lipid-lowering medication, n (%) | 350 (96%) | 352 (96%) | 345 (96%) | 335 (96%) | 0.70 | 331 (93%) | 328 (94%) | 0.64 |
| LDL-C OT (≤2.5 mmol/L) | 247 (68%) | 249 (68%) | 284 (80%) | 241 (69%) | <0.001 | 263 (74%) | 223 (64%) | <0.01 |
| Total ALLP‡ (% LDL-C lowering) | 14.366 | 13.943 | 15.003 | 14.030 | NA | 14.564 | 13.964 | NA |
*At baseline differences not statistically significant at the 5% level.
†Calculated between NCC and usual care (between-groups).
‡ALLP: the ALLP as an indicator of lipid-lowering medication intensity using the method by Besseling et al 12 (ref).
Total ALLP is the sum of the prescribed lipid-lowering potencies (%) per group.
NA, not applicable; OT, on target.